Dirk Burdinski

A Temperature-Sensitive Liposomal 1H CEST and 19F Contrast Agent for MR Image-Guided Drug Delivery

A novel temperature-sensitive liposomal MRI contrast agent has been developed, which allows drug carrier localization using (1)H CEST with simultaneous quantification of the drug release using (19)F MR imaging in response to a local temperature increase.

Relaxation Times in Single Event Electrospraying Controlled by Nozzle Front Surface Modification

Single event electrospraying (SEE) is a method for on-demand deposition of femtoliter to picoliter volumes of fluids. To determine the influence of the size of the meniscus on the characteristics of the single event electrospraying process, glass capillaries were used with and without an antiwetting coating comprising a self-assembled 1H,1H,2H,2H-perfluorodecyltrichlorosilane-based monolayer to control the meniscus size. A large difference was found in driving single event electrospraying from a small meniscus compared to what is needed to generate a single event electrospraying from a large meniscus. Furthermore, after studying the different time constants related to the electrical and the hydrodynamic phenomena, we are able to explain the timing limitations of the deposition process from both a small and a large meniscus. The hydrodynamic relaxation time is significantly reduced in the case of the modified capillary, and the timing of SEE, which determines the deposition time, is limited by the resistor-capacitor RC time of the electrical circuit needed to drive the SEE. We have built a model that describes the almost one-dimensional motion of the liquid in the capillary during pulsing. The model has been used to estimate the hydrodynamic relaxation times related to the meniscus-to-cone and cone-to-meniscus transitions during SEE. By confining the meniscus to the inner diameter of the nozzle, we are able to deposit a volume smaller than 5 pL per SEE.

Iron Oxide Nanoparticle-Micelles (ION-Micelles) for Sensitive (Molecular) Magnetic Particle Imaging and Magnetic Resonance Imaging

Background Iron oxide nanoparticles (IONs) are a promising nanoplatform for contrast-enhanced MRI. Recently, magnetic particle imaging (MPI) was introduced as a new imaging modality, which is able to directly visualize magnetic particles and could serve as a more sensitive and quantitative alternative to MRI. However, MPI requires magnetic particles with specific magnetic properties for optimal use. Current commercially available iron oxide formulations perform suboptimal in MPI, which is triggering research into optimized synthesis strategies. Most synthesis procedures aim at size control of iron oxide nanoparticles rather than control over the magnetic properties. In this study, we report on the synthesis, characterization and application of a novel ION platform for sensitive MPI and MRI. Methods and Results IONs were synthesized using a thermal-decomposition method and subsequently phase-transferred by encapsulation into lipidic micelles (ION-Micelles). Next, the material and magnetic properties of the ION-Micelles were analyzed. Most notably, vibrating sample magnetometry measurements showed that the effective magnetic core size of the IONs is 16 nm. In addition, magnetic particle spectrometry (MPS) measurements were performed. MPS is essentially zero-dimensional MPI and therefore allows to probe the potential of iron oxide formulations for MPI. ION-Micelles induced up to 200 times higher signal in MPS measurements than commercially available iron oxide formulations (Endorem, Resovist and Sinerem) and thus likely allow for significantly more sensitive MPI. In addition, the potential of the ION-Micelle platform for molecular MPI and MRI was showcased by MPS and MRI measurements of fibrin-binding peptide functionalized ION-Micelles (FibPep-ION-Micelles) bound to blood clots. Conclusions The presented data underlines the potential of the ION-Micelle nanoplatform for sensitive (molecular) MPI and warrants further investigation of the FibPep-ION-Micelle platform for in vivo, non-invasive imaging of fibrin in preclinical disease models of thrombus-related pathologies and atherosclerosis.

Targeted LipoCEST Contrast Agents for Magnetic Resonance Imaging: Alignment of Aspherical Liposomes on a Capillary Surface

Molecular imaging is likely to have a significant impact onhealthcare through the early detection of disease on a cellularand molecular level. Among the clinical imaging modalities,magnetic resonance imaging (MRI) offers a unique combi-nation of advantages including the recording of anatomicaland contrast-enhanced images with a high spatial resolution,while avoiding the use of ionizing radiation. The use of MRIfor imaging sparse molecular epitopes present on diseasedcells is hampered by its low sensitivity, which can potentiallybe overcome with new contrast-amplifying nanocarriers.

The Thulium Complex of 1,4,7,10‐Tetrakis{[N‐(1H‐imidazol‐2‐yl)carbamoyl]methyl}‐1,4,7,10‐tetraazacyclododecane (dotami) as a ParaCEST Contrast Agent

1,4,7,10‐Tetrakis{[N‐(1H‐imidazol‐2‐yl)carbamoyl]methyl}‐1,4,7,10‐tetraazacyclododecane (dotami), a tetra(1H‐imidazol‐2‐yl) derivative of the well‐studied octadentate 1,4,7,10‐tetrakis[(carbamoyl)methyl]‐1,4,7,10‐tetraazacyclododecane (dotam) ligand, was synthesized by reaction of 1,4,7,10‐tetraazacyclododecane with N‐(1H‐imidazol‐2‐yl)chloroacetamide in high yield. Its tricationic thulium complex was isolated as a water‐soluble chloride salt. The detection of the mildly acidic amide and amine protons by direct proton NMR in aqueous solution was unsuccessful, but such exchangeable protons could be detected via their chemical exchange‐dependent saturation transfer (CEST) effect. The observed CEST effect was distinctly different from that found for respective dotam complexes and is, therefore, ascribed to exchangeable protons associated with the imidazole substituent.